Interpace Biosciences Inc (IDXG)
1.54
+0.12
(+8.26%)
USD |
OTCM |
Apr 26, 11:24
Interpace Biosciences Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.30M |
| March 31, 2023 | 1.068M |
| December 31, 2022 | -0.472M |
| September 30, 2022 | -3.284M |
| June 30, 2022 | -2.985M |
| March 31, 2022 | -1.273M |
| December 31, 2021 | -1.38M |
| September 30, 2021 | -0.82M |
| June 30, 2021 | -1.867M |
| March 31, 2021 | -5.006M |
| December 31, 2020 | -1.884M |
| September 30, 2020 | -6.084M |
| June 30, 2020 | -0.464M |
| March 31, 2020 | -7.122M |
| December 31, 2019 | -6.427M |
| September 30, 2019 | -4.828M |
| June 30, 2019 | -4.861M |
| March 31, 2019 | -2.972M |
| December 31, 2018 | -1.934M |
| September 30, 2018 | -2.082M |
| June 30, 2018 | -2.552M |
| March 31, 2018 | -2.554M |
| December 31, 2017 | -2.379M |
| September 30, 2017 | -4.341M |
| June 30, 2017 | -4.423M |
| Date | Value |
|---|---|
| March 31, 2017 | -4.149M |
| December 31, 2016 | -0.99M |
| September 30, 2016 | -1.346M |
| June 30, 2016 | -1.301M |
| March 31, 2016 | -3.97M |
| December 31, 2015 | -6.076M |
| September 30, 2015 | -5.437M |
| June 30, 2015 | -2.601M |
| March 31, 2015 | -6.081M |
| December 31, 2014 | -9.965M |
| September 30, 2014 | -8.616M |
| June 30, 2014 | -2.171M |
| March 31, 2014 | -6.977M |
| December 31, 2013 | -3.919M |
| September 30, 2013 | 0.119M |
| June 30, 2013 | -2.307M |
| March 31, 2013 | 0.777M |
| December 31, 2012 | -7.715M |
| September 30, 2012 | 3.606M |
| June 30, 2012 | -4.929M |
| March 31, 2012 | -2.36M |
| December 31, 2011 | -1.109M |
| September 30, 2011 | 1.433M |
| June 30, 2011 | -0.309M |
| March 31, 2011 | 1.627M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.122M
Minimum
Mar 2020
1.068M
Maximum
Mar 2023
-2.788M
Average
-1.884M
Median
Dec 2020
Free Cash Flow (Quarterly) Benchmarks
| Fonar Corp | 3.938M |
| XWELL Inc | -3.467M |
| ProPhase Labs Inc | -1.523M |
| Applied DNA Sciences Inc | -3.758M |
| Veracyte Inc | 13.06M |